Effects of HIV on liver cell populations

HIV and Liver Disease

Volumn , Issue , 2012, Pages 81-90

  Bansal, Meena B ^a   Blackard, Jason T ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955358490     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/9781441917126_9     Document Type: Chapter

References (120)

1. Sheth K, Bankey P. The liver as an immune organ. Curr Opin Crit Care. 2001;7:99-104.
2. Kahn J, Walker B. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339(1):33-9.
3. Keaveny AP, Karasik M. Hepatobiliary and pancreatic infections in AIDS: Part one. AIDS Patient Care STDS. 1998;12(5):347-57.
4. Bonacini M. Hepatobiliary complications in patients with human immunodeficiency virus infection. Am J Med. 1992;92:404-11.
5. Lefkowitch J. Pathology of AIDS-related liver disease. Dig Dis. 1994;12:321-30.
6. Cao Y et al. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol. 1990;64(6):2553-9.
7. Vlahakis S et al. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. J Infect Dis. 2003;188: 1455-60.
8. Littman D. Chemokine receptors: keys to AIDS pathogenesis? Cell Death Differ. 1998;93(5):677-80.
9. Popik W, Pitha P. Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology. 2000;276(1):1-6.
10. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-7.
11. Mellado M et al. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol. 2001;19:397-421.
12. Pearce-Pratt R, Malamud D, Phillips D. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J Virol. 1994;68(5):2898-905.
13. Douglas GC et al. Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Res Hum Retroviruses. 1991;7(9): 735-40.
14. Hatsukari I et al. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J Am Soc Nephrol. 2007;18(3):780-7.
15. Lusso P, Lori F, Gallo R. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J Virol. 1990;64(12):6341-4.
16. Harouse JM et al. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol. 1989;63(6): 2527-33.
17. Liu Y et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol. 2004;78(8):4120-33.
18. Bhattacharya J, Peters PJ, Clapham P. CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo. AIDS. 2003;17 Suppl 4:S3-43.
19. Cameron P et al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 1992;257:383-7.
20. Geijtenbeek T et al. DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell. 2000;100: 587-97.
21. Nguyen DG, Hildreth J. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol. 2003;33(2):483-93.
22. Chen P et al. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol. 2007;81: 12582-95.
23. Popik W, Pitha P. Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology. 2000;2000:1-6.
24. Zheng J et al. gp120-independent HIV infection of cells derived from the female reproductive tract, brain, and colon. J Acquir Immune Defic Syndr. 2006;43(2):137-6.
25. Vidricaire G, Gauthier S, Tremblay M. HIV-1 infection of trophoblasts is independent of gp120/CD4 interactions but relies on heparan sulfate proteoglycans. J Infect Dis. 2007;195(10): 1461-71.
26. Chow YH et al. gp120-Independent infection of CD4(-) epithelial cells and CD4(+) T-cells by HIV-1. J Acquir Immune Defic Syndr. 2002;30(1):1-8.
27. Klasse P, Moore J. Is there enough gp120 in the body fluids of HIV-1 infected individuals to have biologically significant effects. Virology. 2004;323:1-8.
28. Popovic M et al. Perisistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci USA. 2005;102: 14807-12.
29. Santosuosso M et al. HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection. J Infect Dis. 2009;200(7):1050-3.
30. Cummins NW, Rizza SA, Badley AD. How much gp120 is there? J Infect Dis. 2010;201(8):1273-4. author reply 1274-5.
31. Blackard JT, Sherman K. HCV/HIV co-infection: time to re-evaluate the role of HIV in the liver? J Viral Hepat. 2008;15(5):323-30.
32. Cao Y et al. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS. 1992;6(1):65-70.
33. Housset C, Lamas E, Brechot C. Detection of HIV1 RNA and p24 antigen in HIV-1-infected human liver. Res Virol. 1990;141:153-9.
34. Jiang TJ et al. Immunohistochemical evidence for HIV-1 infection in the Liver of HIV-infected patients. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005;19(2):152-4.
35. Hoda SA, White JE, Gerber M. Immunohistochemical studies of human immunodeficiency virus-1 in liver tissues of patients with AIDS. Mod Pathol. 1991;4(5):578-81.
36. Lang ZW et al. A pathological study on liver tissues of patients with HIV infection. Zhonghua Gan Zang Bing Za Zhi. 2005;13(12): 930-2.
37. Banerjee R et al. Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-a. AIDS. 1992;6(10):1127-31.
38. Munshi N et al. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis. 2003;188:1192-204.
39. Balasubramanian A, Ganju R, Groopman J. HCV and HIV envelope proteins collaboratively mediate IL-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem. 2003;278(37):35755-66.
40. Iser DM et al. Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen. J Virol. 2010;84(12): 5860-7.
41. Balasubramanian A et al. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. Clin Infect Dis. 2005;41 Suppl 1:S32-7.
42. Babu CK et al. HIV induces TRAIL sensitivity in hepatocytes. PLoS One. 2009;4(2):e4623.
43. Balasubramanian A, Ganju RK, Groopman JE. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J Infect Dis. 2006;194(5):670-81.
44. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol. 2005;2(2):92-100.
45. Polyak S et al. Elevated levels of interleukin-8 in serum are associated with hepatitis C infection and resistance to interferon therapy. J Virol. 2001;75(13):6209-11.
46. Polyak S et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol. 2001;75(13):6095-106.
47. Khabar K et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon a. J Exp Med. 1997;186(7):1077-85.
48. Canbay A, Friedman S, Gores G. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004;39:273-8.
49. Altavilla G et al. Enhancement of chemical carcinogenesis by the HIV-1 tat gene. Am J Pathol. 2000;157(4):1081-9.
50. Xiao P et al. Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4. AIDS. 2008;22(14):1749-57.
51. Fromentin R, MR T, Tremblay M. Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1- dependent mechanism. Virology. 2010;398:168-75.
52. Zhu M, Duan L, Pomerantz R. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells. AIDS Res Hum Retroviruses. 1996;12(12):1093-101.
53. Pizzella T, Banerjee R. Identification of a human immunodeficiency virus type 1 TAR binding protein in human hepatoblastoma HepG2 cells that trans-activates HIV-1 LTR-directed gene expression. DNA Cell Biol. 1994;13(1):67-74.
54. Hsu ML et al. Cytokine regulation of HIV-1 LTR transactivation in human hepatocellular carcinoma cell lines. Cancer Lett. 1995;94(1): 41-8.
55. Schmitt MP et al. Multiplication of human immunodeficiency virus in primary cultures of human kupffer cells - possible role of liver macrophage infection in the physiopathology of AIDS. Res Virol. 1990;141:143-52.
56. Steffan A et al. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1992;89:1582-6.
57. Ana C, Tuyama A, Hong F, Saiman Y, Wang C, Mosoian A, et al. HIV infects human hepatic stellate cells and promotes collagen I and MCP-1 expression: implications for hepatic fibrosis in HIV/HCV coinfection. Hepatology. 2010;52:612-21.
58. Hong F et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology. 2009;49(6):2055-67.
59. Schwabe R, Bataller R, Brenner D. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol. 2003;285:G949-58.
60. Bruno R et al. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut. 2010;59(4):513-20.
61. Hong F, Bansal M. HIV gp120(X4) promotes hepatic stellate cell activation, fibrogenesis, and proliferation: a potential mechanism for rapid fibrosis progression in HIV/HCV coinfected patients. Hepatology. 2009;50(4) Suppl:128A.
62. Scoazec JY et al. Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV): an ultrastructural study. Am J Pathol. 1988;131(1):38-47.
63. Scoazec JY, Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology. 1990;12(1):505-10.
64. Lafon ME et al. HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture. AIDS. 1994;8(6):747-52.
65. Lafon ME et al. Interaction of human immunodeficiency virus with human macrovascular endothelial cells in vitro. AIDS Res Hum Retroviruses. 1992;8(9):1567-70.
66. Bashirova AA et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med. 2001;193(6):671-8.
67. Hufert FT et al. Human Kupffer cels infected with HIV-1 in vivo. J Acquir Immune Defic Syndr. 1993;6(7):772-7.
68. Schweitzer C et al. Morphine stimulates HIV replication in primary cultures of human Kupffer cells. Res Virol. 1991;142(2-3):189-95.
69. Balagopal A et al. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. AIDS. 2009;23(18):2397-404.
70. Gendrault JL et al. Interaction of cultured human Kupffer cells with HIV-infected CEM cells: an electron microscopic study. Pathobiology. 1991;59(4):223-6.
71. Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol. 2000;15(4):349-56.
72. Bautista AP. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Hepatology. 1997;25(2):335-42.
73. Jacobson-Brown P, Neuman M. Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines. Clin Biochem. 2001;34:167-71.
74. Spanakis N et al. Cytokine serum levels in patients with chronic HCV infection. J Clin Lab Anal. 2002;16:40-6.
75. Fukuda R et al. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver. 1996;16:390-9.
76. Shimoda K et al. Interleukin-8 and hIRH (SDFl-a/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology. 1998;28(1):108-15.
77. Neuman M et al. Serum tumour necrosis factor-a and transforming growth factor-b levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine. 2002;17(2):108-17.
78. Gochee P et al. Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-a and cytochrome P4502E1. J Gastroenterol Hepatol. 2003;18:386-92.
79. Schuppan D et al. Hepatitis C and liver fibrosis. Cell Death Differ. 2002;10 Suppl 1:S59-67.
80. Pal S, Schnapp L. HIV-infected lymphocytes regulate fibronectin synthesis by TGFb1 secretion. J Immunol. 2004;172:3189-95.
81. Navikas V et al. Increased levels of interferon-gamma(IFN- gamma), IL-4 and tranforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol. 1994;96:59-63.
82. Blackard J et al. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol. 2006;78:202-7.
83. Lin W et al. HIV increases HCV replication in a TGF-beta1- dependent manner. Gastroenterology. 2008;164(3):803-11.
84. Friedman S. Cytokines and fibrogenesis. Semin Liver Dis. 1999;19(2):129-40.
85. Masaki N, Fukushima S, Hayashi S. Lower Th-1/Th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C. Dig Dis Sci. 2002;47(10):2163-9.
86. Breen E. Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther. 2002;95(3):295-304.
87. Mehta S et al. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology. 2005;41(1):123-31.
88. Qurishi N et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003;362:1708-13.
89. Kuntzen T et al. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART. AIDS. 2008;22(2):203-10.
90. Mehandru S et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol. 2007;81(2):599-612.
91. Brenchley J et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-71.
92. Balagopal A et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology. 2008;135(1):226-33.
93. Seki E et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13(11):1324-32.
94. Paik YH et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology. 2003;37(5):1043-55.
95. Moriuchi M et al. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. J Clin Invest. 1998;102(8):1540-50.
96. Tedaldi E et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2003;36:363-7.
97. Bica I et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492-7.
98. Salmon-Ceron D et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42(6):799-805.
99. Shi J et al. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer. 2005;92(3): 607-12.
100. World Health Organization. Fact Sheet, Hepatitis B. 2000. 10 Apr 2003. Available from: http://www.who.int/inf-fs/en/fact204.html.
101. Colin JF et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999;29(4):1306-10.
102. Gilson RJ et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS. 1997;11(5):597-606.
103. Yokozaki S et al. Immunological dynamics in hemophiliac patients infected with hepatitis C and human immunodeficiency virus: influence of antiretroviral therapy. Blood. 2000;96(13):4293-9.
104. Thomas D et al. Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis. 2001;183:973-6.
105. Daar E et al. Hepatitis C viral load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis. 2001;193:589-95.
106. Greub G et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800-5.
107. Braitstein P et al. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS. 2006;20(3):323-31.
108. Piroth L et al. Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency viruspositive patients. J Viral Hepat. 2000;7(4):302-8.
109. Piroth L et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. 1998;12(4):381-8.
110. Macias J et al. Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naive patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis. 2003;22:675-80.
111. Ruys T, et al. Impaired recovery of CD4 cells in HIV-1 HCV coinfected patients using highly active antiretroviral therapy. In XV International AIDS Conference. Bangkok, Thailand. 2004.
112. Anderson K, Guest J, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta Cohort Study. Clin Infect Dis. 2004;39:1507-13.
113. Wu X et al. HCV NS3/4A protein activates HIV-1 transcription from its long terminal repeat. Virus Res. 2008;135(1):155-60.
114. Srinivas R et al. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res. 1996;45(2):87-92.
115. Ray RB et al. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 1995;37(3):209-20.
116. Balsano C et al. The hepatitis B virus X gene product transacti- vates the HIV-LTR in vivo. Arch Virol. 1993;8:63-71.
117. Gomez-Gonzalo M et al. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1- binding sites in the HIV-1 long terminal repeat promoter. J Biol Chem. 2001;276(38):35435-43.
118. Ma G, et al. HIV infection of an HCV-producing hepatocyte cell line - a model system for exploring HIV-HCV co-infection in vitro. In 13th International Symposium on Viral Hepatitis and Liver Disease. Washington, DC. 2009.
119. Tardif MR, Tremblay M. Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways. J Virol. 2005;79(7):4316-28.
120. Gordón-Alonso M et al. Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J Immunol. 2006;177(8):5129-37.